FDA says yes to radiation therapy firm's nTRAK patient positioning system:
This article was originally published in Clinica
North American Scientific has received US FDA 510(k) market clearance for its nTRAK stereotactic image guidance system, which is used to position and monitor patients during radiation therapy treatments for head and neck cancers. The system uses an optical camera and fiducial markers attached to a customised bite block to assure that a patient is positioned reproducibly within required tolerances throughout a course of radiation therapy treatments. The Chatsworth, California firm said it expected sales of nTRAK to begin in the fourth quarter of fiscal 2005.
You may also be interested in...
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”
CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.